Skip to main content
Journal cover image

Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity.

Publication ,  Journal Article
Gerhart, JG; Carreño, FO; Ford, JL; Edginton, AN; Perrin, EM; Watt, KM; Muller, WJ; Atz, AM; Al-Uzri, A; Delmore, P; Gonzalez, D ...
Published in: CPT Pharmacometrics Syst Pharmacol
June 2022

Obesity is an increasingly alarming public health threat, with nearly 20% of children classified as obese in the United States today. Children with obesity are commonly prescribed the opioids fentanyl and methadone, and accurate dosing is critical to reducing the risk of serious adverse events associated with overexposure. However, pharmacokinetic studies in children with obesity are challenging to conduct, so there is limited information to guide fentanyl and methadone dosing in these children. To address this clinical knowledge gap, physiologically-based pharmacokinetic models of fentanyl and methadone were developed in adults and scaled to children with and without obesity to explore the interplay of obesity, age, and pharmacogenomics. These models included key obesity-induced changes in physiology and pharmacogenomic effects. Model predictions captured observed concentrations in children with obesity well, with an overall average fold error of 0.72 and 1.08 for fentanyl and methadone, respectively. Model simulations support a reduced fentanyl dose (1 vs. 2 μg/kg/h) starting at an earlier age (6 years) in virtual children with obesity, highlighting the importance of considering both age and obesity status when selecting an infusion rate most likely to achieve steady-state concentrations within the target range. Methadone dosing simulations highlight the importance of considering genotype in addition to obesity status when possible, as cytochrome P450 (CYP)2B6*6/*6 virtual children with obesity required half the dose to match the exposure of wildtype children without obesity. This physiologically-based pharmacokinetic modeling approach can be applied to explore dosing of other critical drugs in children with obesity.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

CPT Pharmacometrics Syst Pharmacol

DOI

EISSN

2163-8306

Publication Date

June 2022

Volume

11

Issue

6

Start / End Page

778 / 791

Location

United States

Related Subject Headings

  • Obesity
  • Methadone
  • Humans
  • Fentanyl
  • Child
  • Analgesics, Opioid
  • Adult
  • 3214 Pharmacology and pharmaceutical sciences
  • 3208 Medical physiology
  • 1116 Medical Physiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gerhart, J. G., Carreño, F. O., Ford, J. L., Edginton, A. N., Perrin, E. M., Watt, K. M., … Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee, . (2022). Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity. CPT Pharmacometrics Syst Pharmacol, 11(6), 778–791. https://doi.org/10.1002/psp4.12793
Gerhart, Jacqueline G., Fernando O. Carreño, Jennifer L. Ford, Andrea N. Edginton, Eliana M. Perrin, Kevin M. Watt, William J. Muller, et al. “Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity.CPT Pharmacometrics Syst Pharmacol 11, no. 6 (June 2022): 778–91. https://doi.org/10.1002/psp4.12793.
Gerhart JG, Carreño FO, Ford JL, Edginton AN, Perrin EM, Watt KM, et al. Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity. CPT Pharmacometrics Syst Pharmacol. 2022 Jun;11(6):778–91.
Gerhart, Jacqueline G., et al. “Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity.CPT Pharmacometrics Syst Pharmacol, vol. 11, no. 6, June 2022, pp. 778–91. Pubmed, doi:10.1002/psp4.12793.
Gerhart JG, Carreño FO, Ford JL, Edginton AN, Perrin EM, Watt KM, Muller WJ, Atz AM, Al-Uzri A, Delmore P, Gonzalez D, Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee. Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity. CPT Pharmacometrics Syst Pharmacol. 2022 Jun;11(6):778–791.
Journal cover image

Published In

CPT Pharmacometrics Syst Pharmacol

DOI

EISSN

2163-8306

Publication Date

June 2022

Volume

11

Issue

6

Start / End Page

778 / 791

Location

United States

Related Subject Headings

  • Obesity
  • Methadone
  • Humans
  • Fentanyl
  • Child
  • Analgesics, Opioid
  • Adult
  • 3214 Pharmacology and pharmaceutical sciences
  • 3208 Medical physiology
  • 1116 Medical Physiology